Mortality associated with moderate and severe mitral regurgitation in 608 570 men and women undergoing echocardiography

Authors

Yih‐Kai Chan (ORCID: https://orcid.org/0000-0003-3836-8145)
David S. Celermajer (ORCID: https://orcid.org/0000-0001-7640-0439)
Simon Stewart (ORCID: https://orcid.org/0000-0001-9032-8998)
Geoff Strange (ORCID: https://orcid.org/0000-0001-6800-7119)
Liza Thomas (ORCID: https://orcid.org/0000-0001-6045-7780)
Elizabeth Davida Paratz (ORCID: https://orcid.org/0000-0002-2122-9889)
G. Scalia (ORCID: https://orcid.org/0000-0003-3453-7802)
David Playford (ORCID: https://orcid.org/0000-0003-4492-1103)
Sarah Ann Harris (ORCID: https://orcid.org/0000-0003-0240-4386)

Institutions

The University of Sydney (AU)
The University of Melbourne (AU)
Royal Prince Alfred Hospital (AU)
The Heart Research Institute (AU)
Westmead Hospital (AU)
St Vincent's Hospital Melbourne (AU)
Prince Charles Hospital (AU)
University of Glasgow (GB)
Australian Catholic University (AU)
The University of Notre Dame Australia (AU)

Publication Details

Journal: Heart
Published: 2024-12-20
DOI: https://doi.org/10.1136/heartjnl-2024-324790
Citations: 6
Primary Topic: Cardiac Valve Diseases and Treatments
Type: article
Field-Weighted Citation Impact: 2.41

Funders

Abbott Laboratories
Bristol-Myers Squibb
Pfizer
Edwards Lifesciences
Sylvia and Charles Viertel Charitable Foundation
National Heart Foundation of Australia
Novo Nordisk
Pfizer Pharmaceuticals
Medical Research Council
National Health and Medical Research Council

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Mortality associated with moderate and severe mitral regurgitation in 608 570 men and women undergoing echocardiography

Yih‐Kai Chan, David S. Celermajer, Simon Stewart, Geoff Strange et al.

Dec 20, 2024

6 citations

Heart

Cardiac Valve Diseases and Treatments

2.41

article

Mortality associated with moderate and severe mitral regurgitation in 608 570 men and women undergoing echocardiography

Yih‐Kai Chan, David S. Celermajer, Simon Stewart, Geoff Strange, Liza Thomas, Elizabeth Davida Paratz, G. Scalia, David Playford, Sarah Ann Harris

December 20, 2024article en

6 citations

Abstract

No abstract available for this paper.

HeartVol. 111(7)

The University of Sydney (AU), The University of Melbourne (AU), Royal Prince Alfred Hospital (AU), The Heart Research Institute (AU), Westmead Hospital (AU), St Vincent's Hospital Melbourne (AU), Prince Charles Hospital (AU), University of Glasgow (GB), Australian Catholic University (AU), The University of Notre Dame Australia (AU)

Abbott Laboratories, Bristol-Myers Squibb, Pfizer, Edwards Lifesciences, Sylvia and Charles Viertel Charitable Foundation, National Heart Foundation of Australia, Novo Nordisk, Pfizer Pharmaceuticals, Medical Research Council, National Health and Medical Research Council

Good health and well-being

Openalex Percentile: Top 9%

Cardiac Valve Diseases and Treatments

2.41

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.